Large chain pharmacies are prepared to boost the dispensing of COVID-19 oral antivirals under President Biden’s Test to Treat Initiative. But participation of smaller pharmacies may depend on a change in prescribing policy and an increase in the dispensing fees they receive – while some physicians worry that even the current plan’s emphasis on clinics puts patients at risk.
The initiative, included in the administration’s National COVID-19 Preparedness Plan, is establishing “one-stop” locations at pharmacy-based clinics, community health centers,...








